Browse studies

Find your next paid study

3,234 recruiting studies matching your filters

Low Field Magnetic Resonance Imaging Assessment With Outpatients

The objective of the study is to perform imaging assessments of an early stage magnetic resonance imaging (MRI) system on patients using low field magnetic str…

Conditions Requiring a Brain Magnetic Resonance Imaging, Head Computerized Tomography, or Head Ultrasound

Estimated

~$10 – $750

Actual pay is set by the research site.

Children's Mercy Hospital Kansas CityNCT05582785

Phase 2

A Phase 2 Multicohort Study to Evaluate Lorigerlimab in Participants With Advanced Solid Tumors

Study CP-MGD019-03 is an open-label study of lorigerlimab in participants with platinum-resistant ovarian cancer (PROC) or clear cell gynecologic cancer (CCGC)…

Platinum-resistant Ovarian CancerPlatinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+8 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

MacroGenics

Observational

CHAMPION: Combining HIV And Meth Prevention and Treatment Interventions Optimized for HIV-Negative MSM

The goal of this randomized controlled trial is to pilot test new mobile health (mHealth) interventions to improve PrEP adherence among HIV-negative men who ha…

PrEP AdherenceMethamphetamine Use DisorderHIV

Estimated

~$10 – $750

Actual pay is set by the research site.

University of California, San DiegoNCT07213258

Phase 1

A Pilot PET Imaging Study of [89Zr]DFO-YS5 for Detection of Cancer in Patients With Various Malignancies

This is a single-center, pilot, PET-imaging study of the novel radiotracer 89Zirconium-89 DFO conjugated to the YS5 monoclonal antibody (\[89Zr\]DFO-YS5) in pa…

Bladder CancerNerve Sheath TumorNerve Sheath Tumors+9 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Robert Flavell, MD, PhDNCT07664397

Observational

The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer

Precision oncology has led to a growing population of adults with advanced cancer living increasingly longer lives in the face of profound uncertainty about th…

Advanced Solid Tumor CancerStage IV Cancer (Solid Tumors Only)Glioblastoma+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Colorado, BoulderNCT07636200

Phase 3

The Use of Nasogastric Tubes And Water-Soluble Contrast In The Management Of Small Bowel Obstruction: A Feasibility Study

Small bowel obstruction (SBO) is one of the most common causes of serious gastrointestinal disease in the US. Adhesion-related SBO (aSBO) is usually treated by…

Adhesive Small Bowel Obstruction

Estimated

~$50 – $1,500

Actual pay is set by the research site.

University of California, Los AngelesNCT06182319

Observational

Investigating a Truncated Version of paiTBS in Treatment-Naive Adolescents With Depression: An Open-Label Acceptability Trial

This is a single-site open-label clinical trial of fMRI-guided accelerated intermittent theta burst stimulation. The goal of this clinical trial is to learn if…

Major Depressive DisorderDepression in AdolescenceDepression+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Texas at AustinNCT06523439

Phase 2

An Open-label, Multicenter Phase II Study to Compare the Efficacy of Carboplatin as First-line Followed by Second-line Olaparib Versus Olaparib as First-line Followed by Second-line Carboplatin in the Treatment of Patients With Castration Resistant Prostate Cancer Containing Homologous Recombination Deficiency

This is an unblinded, randomized clinical study comparing the efficacy of DNA damaging chemotherapy using carboplatin, to standard of care therapy for patients…

Metastatic Castrate Resistant Prostate CancerBARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2RAD51B, RAD51C, RAD51D, or RAD54L Mutations

Estimated

~$75 – $1,800

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT04038502

Phase 1

A Phase 1 and Randomized Phase 2 Trial of Pidnarulex (CX-5461) and Cemiplimab (REGN2810) in Refractory Microsatellite Stable Colorectal Cancer

This phase I/II trial studies the side effects and best dose of pidnarulex when given together with cemiplimab and to see how well it works in treating patient…

Metastatic Colorectal AdenocarcinomaRefractory Colorectal AdenocarcinomaStage III Colorectal Cancer AJCC v8+2 more

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT07147231

Phase 2

A PHASE 2, RANDOMIZED, DOUBLE-BLIND, CLINICAL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MRNA VACCINES AGAINST INFLUENZA IN ADULTS 18 YEARS OF AGE AND OLDER

The purpose of this study is to learn about safety in participants taking the study vaccine (mRNA-based vaccine) and the ability of the study vaccine to trigge…

Healthy Adults

Estimated

~$75 – $3,000

Actual pay is set by the research site.

PfizerNCT07431853

A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement

The major goal of this study is to determine the incidence of adrenal insufficiency in patients with endogenous Cushing syndrome receiving osilodrostat treatme…

Endogenous Cushing SyndromeAdrenal InsufficiencyHypercortisolism

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MichiganNCT06430528

Phase 1

A Phase 1, Randomized, Open-Label, Parallel-Group Trial Comparing the Pharmacokinetics of Navenibart Administered by Vial/Syringe Versus Autoinjector in Healthy Adult Volunteers

The goal of this clinical trial is to compare two different presentations (vial and syringe versus autoinjector) of navenibart in healthy adult volunteers. The…

Healthy Adult Participants

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Astria Therapeutics, Inc.NCT07635095